Still trying to my head around all this stuff so excuse my ignorance, but when comparing say MSB against Gilead, or any treatment, wouldn't these trials with relatively small numbers be easily skewed by the underlying non-conforming health of the patients? After all, they're all going to be different in some way, which can increase or decrease their response to treatment and may be the differences in percentage terms. I would imagine they'd take this in to account when assessing efficacy.
- Forums
- ASX - By Stock
- MSB
- Gilead vs Mesoblast
Gilead vs Mesoblast, page-271
-
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
94.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.073B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 974 | 96.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
90.5¢ | 13354 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 546 | 0.985 |
4 | 645 | 0.965 |
1 | 1005 | 0.950 |
2 | 1063 | 0.945 |
5 | 23592 | 0.940 |
Price($) | Vol. | No. |
---|---|---|
0.915 | 4 | 1 |
0.930 | 790 | 1 |
0.935 | 10000 | 1 |
0.940 | 15642 | 6 |
0.945 | 20000 | 1 |
Last trade - 09.52am 03/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online